A – 6 Curation and Characterization of Cognitive Screener Scores in the VA Million Veteran Program (MVP): Implications for Cognitive Aging and Alzheimer’s Disease and Related Dementias

Abstract Objective Electronic health record (EHR)-linked biorepositories provide powerful opportunities to advance epidemiological research in Alzheimer’s disease and related dementias (ADRD). The goal of this study was to determine the feasibility of using data from the VA Million Veteran Program (MVP)—the largest EHR-linked biorepository—to curate cognitive screener scores. We also examined associations between cognitive screener scores and apolipoprotein E (APOE), the strongest genetic risk factor for late-onset ADRD. Method The sample (N=49,555; 7.4% women) included a multiethnic cohort (European [69.3%], African [20.7%], Hispanic [9.1%], and Asian [0.8%]) with EHR-extracted and cleaned Mini-Mental State Examination (MMSE) total scores. Approximately 30.8% were APOE e4 carriers, and 25.8% had multiple MMSE scores. Analysis of variance was performed to examine cross-sectional associations between APOE e4 dosage (0, 1, 2) and first (M=27.3, SD=3.5) and lowest (M=26.7, SD=4.2) MMSE total scores. Results There was a significant dose-response relationship between APOE e4 genotype and MMSE scores. Homozygote e4 carriers performed worse than heterozygote e4 carriers (mean difference: first=-0.5; lowest=-0.9), who in turn performed worse than non-carriers (mean difference: first=-0.4; lowest=-0.6) for both first and lowest scores. Results remained unchanged after adjusting for genetic ancestry, sex, and age (all ps<.001; ηp2=.08-.11). Conclusion This proof-of-concept study is the first to demonstrate the feasibility of leveraging MVP to examine EHR-extracted cognitive test scores. Findings highlight the potential for harnessing MVP to explore additional genetic, environmental, and clinical factors that contribute to cognitive aging and ADRD in a diverse sample, offering a scalable framework for future studies on risk stratification and intervention.

Authors

Publication Details

Journal
Archives of Clinical Neuropsychology
Published
2025-09-26
DOI
https://doi.org/10.1093/arclin/acaf084.030
Primary Topic
Frailty in Older Adults
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A – 6 Curation and Characterization of Cognitive Screener Scores in the VA Million Veteran Program (MVP): Implications for Cognitive Aging and Alzheimer’s Disease and Related Dementias

Victoria C. Merritt, George Asimakopoulos, Mark W. Logue, Francesca V. Lopez et al.
Archives of Clinical Neuropsychology
Frailty in Older Adults
article

A – 6 Curation and Characterization of Cognitive Screener Scores in the VA Million Veteran Program (MVP): Implications for Cognitive Aging and Alzheimer’s Disease and Related Dementias

Victoria C. Merritt, George Asimakopoulos, Mark W. Logue, Francesca V. Lopez, Rui Zhang
article en

Abstract

Abstract Objective Electronic health record (EHR)-linked biorepositories provide powerful opportunities to advance epidemiological research in Alzheimer’s disease and related dementias (ADRD). The goal of this study was to determine the feasibility of using data from the VA Million Veteran Program (MVP)—the largest EHR-linked biorepository—to curate cognitive screener scores. We also examined associations between cognitive screener scores and apolipoprotein E (APOE), the strongest genetic risk factor for late-onset ADRD. Method The sample (N=49,555; 7.4% women) included a multiethnic cohort (European [69.3%], African [20.7%], Hispanic [9.1%], and Asian [0.8%]) with EHR-extracted and cleaned Mini-Mental State Examination (MMSE) total scores. Approximately 30.8% were APOE e4 carriers, and 25.8% had multiple MMSE scores. Analysis of variance was performed to examine cross-sectional associations between APOE e4 dosage (0, 1, 2) and first (M=27.3, SD=3.5) and lowest (M=26.7, SD=4.2) MMSE total scores. Results There was a significant dose-response relationship between APOE e4 genotype and MMSE scores. Homozygote e4 carriers performed worse than heterozygote e4 carriers (mean difference: first=-0.5; lowest=-0.9), who in turn performed worse than non-carriers (mean difference: first=-0.4; lowest=-0.6) for both first and lowest scores. Results remained unchanged after adjusting for genetic ancestry, sex, and age (all ps<.001; ηp2=.08-.11). Conclusion This proof-of-concept study is the first to demonstrate the feasibility of leveraging MVP to examine EHR-extracted cognitive test scores. Findings highlight the potential for harnessing MVP to explore additional genetic, environmental, and clinical factors that contribute to cognitive aging and ADRD in a diverse sample, offering a scalable framework for future studies on risk stratification and intervention.

Archives of Clinical NeuropsychologyVol. 40(Supplement_2)
Openalex Percentile: Top 68%
Frailty in Older Adults
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.